Akebia Therapeutics
AKBA
#7121
Rank
NZ$0.70 B
Marketcap
$3.24
Share price
2.23%
Change (1 day)
71.22%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of September 2024 : NZ$60.16 Million

According to Akebia Therapeutics's latest financial reports the company has NZ$60.16 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$67.87 M-52.36%
2022-12-31NZ$0.14 B-35.03%
2021-12-31NZ$0.21 B-41.11%
2020-12-31NZ$0.37 B69.81%
2019-12-31NZ$0.21 B-54.27%
2018-12-31NZ$0.47 B7.16%
2017-12-31NZ$0.44 B19.06%
2016-12-31NZ$0.37 B85.79%
2015-12-31NZ$0.20 B45.52%
2014-12-31NZ$0.13 B250.89%
2013-12-31NZ$39.61 M1885.99%
2012-12-31NZ$1.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$15.93 B 26,388.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.79 B 41,112.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$35.89 B 59,563.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.43 B 618.70%๐Ÿ‡บ๐Ÿ‡ธ USA